scholarly journals Genetic vulnerability of exposures to antenatal maternal treatments in 1– to 2‐month‐old infants

Infancy ◽  
2021 ◽  
Vol 26 (3) ◽  
pp. 515-532
Author(s):  
Kristina Denisova

Crop Science ◽  
1977 ◽  
Vol 17 (4) ◽  
pp. 632-634 ◽  
Author(s):  
N. L. Taylor ◽  
P. B. Gibson ◽  
W. E. Knight


PLoS ONE ◽  
2016 ◽  
Vol 11 (10) ◽  
pp. e0163739 ◽  
Author(s):  
Luciano Rogério Braatz de Andrade ◽  
Roberto Fritsche Neto ◽  
Ítalo Stefanine Correia Granato ◽  
Gustavo César Sant’Ana ◽  
Pedro Patric Pinho Morais ◽  
...  


2014 ◽  
Vol 49 (suppl 1) ◽  
pp. i2-i2
Author(s):  
I. Sora


Author(s):  
Tolulope I. N. Perrin-Stowe ◽  
Yasuko Ishida ◽  
Emily E. Terrill ◽  
Dan Beetem ◽  
Oliver A. Ryder ◽  
...  


Author(s):  
Stephanie J Wilson ◽  
Avelina C Padin ◽  
Daniel J Birmingham ◽  
William B Malarkey ◽  
Janice K Kiecolt-Glaser


1987 ◽  
Vol 21 (2) ◽  
pp. 197-208 ◽  
Author(s):  
Fiona K. Judd ◽  
Graham D. Burrows ◽  
David A. Hay

Many studies have suggested that a genetic predisposition to the development of panic disorder exists. These studies are examined and their limitations discussed. It is suggested that only by the analysis of comprehensive family and twin data, coupled with other measures such as the search for possible single gene association or linkage and study of the children of panic disorder patients, will the mechanism for the ‘familiality’ noted in panic disorder patients be elucidated. Delineation of the mode of transmission of panic disorder may allow preventative intervention with those at risk before they develop panic.



1993 ◽  
Vol 23 (2) ◽  
pp. 361-371 ◽  
Author(s):  
Kenneth S. Kendler ◽  
Michael C. Neale ◽  
Ronald C. Kessler ◽  
Andrew C. Heath ◽  
Lindon J. Eaves

SynopsisIn a population based sample of 2163 personally interviewed female twins, substantial comorbidity was observed between DSM-III-R defined major depression (MD) and 4 subtypes of phobia: agoraphobia, social phobia, animal phobia and situational phobia. However, the level of comorbidity of MD with agoraphobia was much greater than that found with the other phobic subtypes. We conducted bivariate twin analyses to decompose the genetic and environmental sources of comorbidity between MD and the phobias. Our results suggest that a modest proportion of the genetic vulnerability to MD also influences the risk for all phobic subtypes, with the possible exception of situational phobias. Furthermore, the magnitude of comorbidity resulting from this shared genetic vulnerability is similar across the phobic subtypes. By contrast, the non-familial environmental experiences which predispose to depression substantially increase the vulnerability to agoraphobia, have a modest impact on the risk for social and situational phobias and no effect on the risk for animal phobias. The increased comorbidity between MD and agoraphobia results, nearly entirely, from individual-specific environmental risk factors for MD which also increase the risk for agoraphobia but not for other phobias.



2019 ◽  
pp. 1-6 ◽  
Author(s):  
Carsten Hjorthøj ◽  
Md Jamal Uddin ◽  
Theresa Wimberley ◽  
Søren Dalsgaard ◽  
David M. Hougaard ◽  
...  

Abstract Background Cannabis use and cannabis use disorder (CUD) is increased in patients with schizophrenia. It is important to establish if this is explained by non-causal factors, such as shared genetic vulnerability. We aimed to investigate whether the polygenic risk scores (PRS) for schizophrenia and other psychiatric disorders would predict CUD in controls, patients with schizophrenia, and patients with other psychiatric disorders. Methods We linked nationwide Danish registers and genetic information obtained from dried neonatal bloodspots in an observational analysis. We included people with schizophrenia, other psychiatric disorders, and controls. The exposures of interest were the PRS for schizophrenia, attention-deficit hyperactivity disorder (ADHD) autism spectrum disorder, and anorexia nervosa. The main outcome of interest was the diagnosis of CUD. Results The study included 88 637 individuals. PRS for schizophrenia did not predict CUD in controls [hazard ratio (HR) = 1.16, 95% CI 0.95–1.43 per standard-deviation increase in PRS, or HR = 1.47, 95% CI 0.72–3.00 comparing highest v. remaining decile], but PRS for ADHD did (HR = 1.27, 95% CI 1.08–1.50 per standard-deviation increase, or HR = 2.02, 95% CI 1.27–3.22 for the highest decile of PRS). Among cases with schizophrenia, the PRS for schizophrenia was associated with CUD. While CUD was a strong predictor of schizophrenia (HR = 4.91, 95% CI 4.36–5.53), the inclusion of various PRS did not appreciably alter this association. Conclusion The PRS for schizophrenia was not associated with CUD in controls or patients with other psychiatric disorders than schizophrenia. This speaks against the hypothesis that shared genetic vulnerability would explain the association between cannabis and schizophrenia.



Sign in / Sign up

Export Citation Format

Share Document